as weil as peptide yield determined. Although desired peptides were partially rejected by the ultrafiltration membrane du ring the continuous process, 2.65 9 of these small molecules (500 to 780 Da) were obtained in the final powder. 
INTRODUCTION
The primary function of dietary proteins is to supply the body adequately with essential amino-acids and organic nitrogen. Attention is now increasingly paid to food proteins, in particular milk proteins, which are recognized as a source of biologically active peptides (Fiat and Jollès, 1989; Maubois and Léonil, 1989) . A first bioactive fraction from~-casein was identified in the late 70's as having morphine-like properties (Brantl et al, 1979) . Since that time a great deal of research has been carried out and, up to day, about 12 active sequences have been identified in various casein molecules (as,ã nd K caseins). Such bioactive peptides can be released by enzymatic proteolysis in vitro and in vivo. During an in vitro digestion process, the limiting step is the purification of the desired peptide from the reaction mixture.
A continuous recycle ultrafiltration (UF) membrane reactor, which combines enzymatie hydrolysis of substrate and simultaneous separation of the products, may be an attractive process for specifie peptide separation. This bioreactor configuration has been widely used to produce hydrolysates with irnproved nutritional and/or functional properties (Maubois et al, 1979; Cheryan and Mehaia, 1986) . In a previous work, we reported the first application of this continuous process for bioactive peptide preparation using caseinomacropeptide (CMP) / trypsin as model (Bouhallab et al, 1992) . Small peptidic sequences derived from the N-terminal part of CMP have been identified as antithrombotic peptides which inhibited platelet aggregation and/or binding of fibrinogen to ADP treated blood platelets (Jollès et al, 1986; Maubois etai, 1991) .
The continuous production of these small molecules in a membrane reactor was made possible because of the high molecular mass difference between these peptides and the other components in the system such as enzyme, substrate and complementary large fragments. In the present study, kinetic parameters of batch and continuous hydroIysis were compared. Productivity and peptide yield were determined on the basis of gram-scale preparation of these bioactive molecules. 
MATERIALS AND METHODS

Reagents
Batch hydrolysis of caseinomacropeptide
To investigate batch productivity, hydrolysis of CMP (187 urnol r ') was performed at 40°C in 10 rnrnol r ' sodium phosphate buffer (pH 7.5).
Digestion
was started by trypsin addition (enzyme/substrate = 1/1560 (mol/mol)). Alter 3 h, the reaction was stopped by adjusting the solution to pH 2.2 with 5% TFA. To assess batch kinetic parameters from initial reaction rates, various substrate concentrations (from 47 to 933~moll-1) were hydrolysed by addition of trypsin (0.2 umot r').
Continuous hydrolysis in a membrane reactor
Reactor system
The main components of the reactor included a 1.5 1 vat coupled to a membrane module via a volumetrie pump (PCM 1.7 1 10 type, Vanves, France), a heat exchanger, a pl-l-stat apparatus, two pressure gauges, an electropneumatic valve (Masoneillan, Varipak type, Neuilly-sur-Seine, France), Iwo flowmeters for retentate and permeate, and a peristaltic pump to feed fresh substrate solution. The volume (V) was maintained constant by matching the incoming feed flow rate to the permeate outflow (J).
Continuous experiments
Continuous experiments were conducted by first loading the reactor tank with the required substrate concentration. After adjusting temperature and pH, the enzyme solution was added. The pump connecting the tank to the membrane module was th en activated and the system regulated. Experiments reported here were conducted at 40°C, reactor volume 1.25 l, tangential flow rate 2.95 m g-1, permeate flow 0.25 or 0.5 1h-1 , pH maintained at 7.5 by continuous addition of 0.1 N NaOH, time duration 7 h. The influence of various substrate concentrations was studied with a single M5 inorganic membrane tube (TechSep, Miribel, France), which is a composite UF membrane of Zr02 filtering layer on a carbon support (6 mm id, 2.26 10-2 m 2 membrane area, molecular mass eut-off (MMCO) of 10 kDa). Before and after each run, the system was cleaned as described by Nau et al (1993) . The water permeability of a cleaned membrane was 86 1h-1 m-2 bar" at 50°C. Caseinomacropeptide (Me 7500 Da) at 1 9 1-1 was completely rejected by this membrane at neutral pH. The same phenomenon has been reported by Tanimoto et al (1990) .
For large-scale preparation of bioactive peptides, a high surface area membrane was used (Spiral-Wound UF Cartridge S10Y3, MMCO of 3 kDa, 0.96 m 2 , Amicon, Lexington, MA, USA). ln this last experiment, reactor volume and permeate flow were 1.91 and 1.71 h-1 respectively. Continuous hydrolysis was carried out during 6 h by addition of 1.6 umol r' of trypsin at two times, ie 0 and 3 h. The permeate obtained (10.1 1)was concentrated to 0.82 1by an organic nanofiltration membrane R76A (Millipore) and then the retentate was freeze-dried. Operating conditions for the nanofiltration experiment were as follows: T = 40°C, pH 8, tangential flow rate = 0.6 m S-1, transmembrane pressure (TP) = 10.7 bar (TP was controlled by graduai increase from 1 to 10.7 bar (1 bar min-1 )).
Complete retention of trypsin in the presence of CMP by both UF membranes used was 253 checked. No tryptic activity was detected in the permeates.
During ail continuous experiments, samples from retentate and permeate were withdrawn, added to 5% TFA, and when needed concentrated by Speed-vac. Bioactive peptide Iiberation was quantified by RP-HPLC.
Analytical methods
Nitrogen content of the initial substrate and peptide powder were determined by the Kjeldahl procedure.
RP-HPLC analyses
Chromatographie analyses were carried out on an Ultrabase column C18 (4.5 x 250 mm; Shandon, Eragny, France). Operating conditions were as previously reported (Léonil and Mollé, 1990) . Peptides were quantified from the Iinear relation between peak areas and injected amounts of individual peptides Met106-LYS112 and Met106-LYSll1. Bioactive peptides LYS112-LYS116and Asn113-LYS116were quantified only in the final powder.
Electro-spray mass analyses were carried out on a Sciex API-I quadripole mass spectrometer (Thornhill, Ontario, Canada) equipped with an atmospheric pressure ionisation source. The samples, diluted in 80% aqueous acetonitrile and 0.1 % TFA, were introduced at 5 fil mirr ' flow rate by a 22 infusion pump (Harvard apparatus, MA, USA)
RESUL TS AND DISCUSSION
Batch experiments
CMP, a C-terminal part of x-cassin (Met106-Val1~9; average Mr = 7500 Da) is an heterogeneous mixture with respect to its different degrees of carbohydrate substitution. Its tryptic hydrolysis (fig 1) leads to the liberation of a family of four small antithrombotic peptides: Met106-LYS112(Mr = 785 Da); Met106-LYS111(656 Da); LYS112-LYS116 (632 Da); Asn113-LYS116(503 Da); and the C-terminal complementary glycosylated macropeptide Thr117-VaI169(average Mr =6230 Da). Using TPCK-treated trypsin and on the basis of 1 a rg e f rag men ts, ie Ly s112-VaI169, Asn113-VaI169 and Thr117-Va1169 quantification, Léonil and Mollé (1990) reported that among the three sensitive bonds, LYS111-LYS112and Lys112-Asn113 were hydrolysed with the same kinetic parameters (Km = 0.2 rnmol r': !<cat = 2.97 S-1) and more rapidly than the LYS116-Thr117bond. In the present study, hydrolysis of both highly sensitive bonds was studied by monitoring the liberation of the two peptides Met106-LYS111 and Met106-LYS112. The kinetic constants for the batch reactor were evaluated with various CMP concentrations. The MichaelisMenten constants determined from the Lineweaver-Burk plot are reported in table 1. The Km value compares weil with that reported for the same peptide bond hydrolysis on carbohydrate-free CMP followed by the liberation of large peptides (Léonil and Mollé, 1990 ).
However, !<cat determined in the present work was 2-fold higher than that already reported. This discrepancy may be attributed to differences in specific activities of the two trypsin preparations.
Continuous reactor kinetics
The model used for the hydrolysis of CMP in the membrane reactor is based on the one developed by Deeslie and Cheryan (1981 where v = rate of reaction at steady-state of the process (mmol peptides 1-1 mirr '): J = permeate flow (ml rnirr '): X = substrate conversion (% of peptides produced); So = initial CMP concentration (mmol 1-1 ); V = reactor volume (ml).
The data obtained with the continuous reactor at various substrate concentrations are shown in figure 2. An apparent steady-state was reached after 90 min under these conditions, taking longer at higher substrate concentration as expected according to the reactor configuration (Mannheim and Cheryan, 1990) . The steady-state values were used to calculate X for reaction rate determination (equation 1). The linearization plot for the continuous process is shown in figure 3 and the correspondingkinetic constants are given in table 1. Whereas the Km value was the same as the batch reactor, Vmax and !<cal were 10-fold lower during the continuous system, indicating significant reduction in enzyme activity. Since the same enzyme concentration was used, these values mean that only 10% of the initial enzyme concentration was being utilized in the membrane reactor. Enzyme leakage through UF membrane and/or thermal inactivation are known to affect the catalyst during continuous process (Deeslie and Cheryan, 1982) . However, complete rejection of the enzyme by the membrane during continuous hydrolysis of CMP was checked by incubation of concentrated permeates withdrawn at steadystate with synthetic substrate. Also, the activity reduction may be caused by some shear stress resulting from the pump, pressure valve and/or membrane module (Charm and Wong, 1981) . However, kinetic parameters determined in continuous reactor are only apparent values because, in the kinetic model used, rejection of product by the membrane was not taken into account. In this model, it was assumed that there were no mass transfer limitations. In fact, conversion rate (X) as expressed in the model, integrates enzymatic reaction as weil as ultrafiltration behaviour of the products. This cou Id lead to an underestimation of peptide concentration released at steady-state and consequently of the real activity of the enzyme. The average rejection coefficient of these praducts at steady-state, as determined by RP-HPLC, varied from 20 to 50% depending on the substrate concentration used.
The determined kinetic parameters were explored for large scale preparation of bioactive peptide fraction. The Km value establishes an approximate value of substrate concentration to be used. A higher substrate concentration would cause a rapid decrease in performance due to fouling caused by the accumulation of high molecular mass products.
Production of bioactive peptides: application experiment
Continuous production of bioactive peptides Irorn CMP at 373 umol r' (total substrate treated = 34 g; enzyme, 2 x t.ô urnol r") was done according to the scheme presented in figure 4 . The yield of bioactive peptides during various steps is shown in table Il. During the continuous hydrolysis (step 1) 59% of the expected amount of the two peptides Met106-LYS111and Met106-LYS112was obtained in the permeate without the diafiltration step of the retentate. Mass spectroscopy analysis of the retentate at the end of the continuous hydralysis (after 6 h) indicates that total conversion of the two bonds LYS111-LYS112 and LYS112-Asn113was reached (no native CMP was detected). Hence, this relatively low Step 1: continuo us hydrolysis in a membrane reactor; step 2: nanofiltration of permeate step 1; step 3: freeze-drying of retentate step 2. aTheoretical amount is equivalent to 100% hydrolysis at the three basic sites of CMP (see fig 1) ; bquantified only in the final powder; cyield of concentration steps. yield is due to rejection by the UF membrane.
The average rejection coefficient (cr) was 63%, as determined from yield equation reported by Cheryan (1986) where Cp and Co are peptide concentrations in the permeate and feed solution respectively; Vp and Va are volume of the permeate and total volume treated respectively; and VCR is volume concentration ratio. The downstream steps were carried out without major loss of the bioactive peptides. The good yield after nanofiltration (VCR = 12.5)
indicates that this membrane technology is weil suited for concentrating small peptides. The final product contained 2.65 9 of bioactive peptides (including bioactive peptides derived from the hydrolysis of LYS116-Thr117 bond). This represents 53% of the expected theoretical amount.
The productivity of the continuous process expressed as mass bioactive peptides obtained/mass enzyme was 18.5. Although a significant part of bioactive peptides was re- jected by the UF membrane, the productivity of this process was 3-fold higher than that expected at 100% conversion (100% hydroIysis of the three bonds) in a batch system after only 5.5 reactor volume replacements. Performance of the continuous system would be greater taking into account that the batch process requires added steps such as enzyme inactivation and bioactive peptide separation from the reaction mixture.
The purity of bioactive peptides in the final product, expressed on molar basis reached 82%. However, on the basis of mass ratio, the purity decreased to about 50% due to the presence of 2.5 9 of high molecular mass peptides. The transfer of this material through the UF-membrane, combined with the above-mentioned relatively high bioactive peptide rejection, may be explained bya change of membrane selectivity during the continuous hydrolysis step.
CONCLUSION
A continuous recycle membrane reactor combined with nanofiltration is a powerful process for large-scale production and concentration of bioactive peptides derived from food proteins. In this study, 2.65 9 of small bioactive peptides (500 to 780 Da) were obtained from continuous tryptic hydrolysis of caseinomacropeptide (6 h) and nanofiltration of the permeate (1 hl. However, the purity of the final product (mass of bioactive peptides / mass of total peptides) was not as high as expected due to the transmission of high molecular mass peptides (Mr > 6200 Da) through the ultrafiltration membrane (eut-off 3 kDa). Higher purity should be obtained by using UF membrane with lower eut-off or by earrying out another UF of the permeate in order to deerease large moleeular mass peptides.
At enzymatie level, the kcat value for the eontinuous operation was 1Q-fold lower than for the bateh proeess. However, this may not refleet the real enzymatie aetivity in the retentate side, sinee rejeetion of individual produets was not included. A new kinetie model that ineorporates rejeetion is needed for better estimation of kinetie parameters in the retentate side.
